Synthesis and antiviral activities of 1,3-oxathiolanyl nucleosides with 5-hydroxymethyl substituent
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chun M.W. | - |
dc.contributor.author | Choi S.P. | - |
dc.contributor.author | Kim M.J. | - |
dc.contributor.author | Bae C.J. | - |
dc.contributor.author | Moon H.R. | - |
dc.contributor.author | Kim H.-D. | - |
dc.contributor.author | Jeong L.S. | - |
dc.date.available | 2021-03-12T02:40:24Z | - |
dc.date.issued | 1999-04 | - |
dc.identifier.issn | 0732-8311 | - |
dc.identifier.issn | 1532-2335 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/17463 | - |
dc.description.abstract | Novel 1,3-oxathiolanyl pyrimidine nucleosides with 5-hydroxymethyl substituent were synthesized starting from D-mannose and evaluated for antiviral activities against HIV-1, HSV type 1,2 and HCMV. | - |
dc.format.extent | 2 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Marcel Dekker Inc. | - |
dc.title | Synthesis and antiviral activities of 1,3-oxathiolanyl nucleosides with 5-hydroxymethyl substituent | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1080/15257779908041515 | - |
dc.identifier.scopusid | 2-s2.0-0010014517 | - |
dc.identifier.wosid | 000081357300031 | - |
dc.identifier.bibliographicCitation | Nucleosides and Nucleotides, v.18, no.4-5, pp 615 - 616 | - |
dc.citation.title | Nucleosides and Nucleotides | - |
dc.citation.volume | 18 | - |
dc.citation.number | 4-5 | - |
dc.citation.startPage | 615 | - |
dc.citation.endPage | 616 | - |
dc.type.docType | Conference Paper | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | 1,3 oxathiolanyl derivative | - |
dc.subject.keywordPlus | 5 hydroxymethyl derivative | - |
dc.subject.keywordPlus | antivirus agent | - |
dc.subject.keywordPlus | nucleoside derivative | - |
dc.subject.keywordPlus | unclassified drug | - |
dc.subject.keywordPlus | antiviral activity | - |
dc.subject.keywordPlus | conference paper | - |
dc.subject.keywordPlus | drug structure | - |
dc.subject.keywordPlus | drug synthesis | - |
dc.subject.keywordPlus | Herpes simplex virus 1 | - |
dc.subject.keywordPlus | Herpes simplex virus 2 | - |
dc.subject.keywordPlus | Human cytomegalovirus | - |
dc.subject.keywordPlus | Human immunodeficiency virus 1 | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | reaction analysis | - |
dc.subject.keywordPlus | Herpes | - |
dc.subject.keywordPlus | Human herpesvirus 1 | - |
dc.subject.keywordPlus | Human herpesvirus 2 | - |
dc.subject.keywordPlus | Human herpesvirus 5 | - |
dc.subject.keywordPlus | Human immunodeficiency virus | - |
dc.subject.keywordPlus | Human immunodeficiency virus 1 | - |
dc.identifier.url | https://www.tandfonline.com/doi/abs/10.1080/15257779908041515 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.